Login to Your Account



Primed to mine: Frazier raises $262M therapeutics fund

By Michael Fitzhugh
Staff Writer

Thursday, October 29, 2015
Funded and ready to put its "gem cutters" to work, Frazier's managing general partner, Patrick Heron, told BioWorld Today the company has closed its eighth fund, a $262 million tool for finding "diamonds in the rough" of early stage therapeutics companies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription